If we don't act now, we risk losing the institutions that keep our society open, informed and free
Roy Cohn, once an attorney and confidant of Donald Trump, talking to Sen. Joseph McCarthy (right), circa 1954. Photo by Keystone/.
I got an unexpected email last week from the federal Centers for Disease Control and Prevention.
It referenced the Prevention Research Center at the University of Minnesota, where I lead work to promote healthy eating and wellbeing among children. The email was notification of a survey for grantees, unlike any I'd seen before in my 20+ years as a researcher, with questions like:
'Can you confirm that your organization does not work with entities associated with communist, socialist, or totalitarian parties, or any party that espouses anti-American beliefs?'
'What impact does this project have on protecting religious minorities, promoting religious freedom, and combating Christian persecution?'
'Is your organization compliant with the latest Mexico City Policy?'
Responses were mandated by midnight the following day, just over 24 hours later. The urgency — and implied threat to our work — seemed designed to sow fear and uncertainty.
Prior to receiving funding in 2024, our work and team were scrutinized through multiple layers of scientific and administrative review. Our institution provided all necessary government assurances. There were no doubts raised about our work or the context in which we do it.
The questions seemed to be less about our work, and more about advancing an unpredictable and politically motivated agenda in the realm of scientific research.
As in psychological warfare — where destabilization is sought through confusion, fear, and mistrust — our current climate of chaos and apprehension has gripped researchers, federal workers, and Americans who rely on the government. Policies change without warning, leaving us scrambling to comply with conflicting directives. Uncertainty reigns — many of us aren't sure if our next project will be delayed, canceled or targeted as an example of defiance.
Last week, $400 million in federal funding granted to Columbia University was canceled due to accusations the university failed to address antisemitism on campus. The University of Minnesota was named as one of five universities under similar investigation by the Trump administration in February. As of March 10th, 60 colleges and universities have been named as subjects of investigation. Ostensibly about protecting Jewish students and faculty, these investigations and enforcement actions could in reality be intended to stifle and ultimately censor speech that isn't aligned with Trump's political ideology.
The president's unpredictable, often unexplained policy changes affect us all. The CDC's ability to respond to outbreaks of diseases like flu, Ebola, and COVID-19 has been severely hindered since firing 700 staffers, with many more layoffs likely coming soon. Firings, cuts and funding freezes at the NIH have stalled critical research on diseases like cancer, heart disease and Alzheimer's. These setbacks undermine American health and threaten economic growth, as every $1 invested in NIH generates $2.46. The dismantling of federal training programs and university infrastructure weakens future generations of skilled workers — doctors, engineers, teachers and others we need to drive economic growth, compete globally, and solve complex problems.
Compounding today's uncertainty is the president's lack of tolerance for dissent. History shows us the dangers of suppressing opposing views. McCarthyism, for example, fueled a climate of suspicion and alarm in the 1950s, when dissenters were targeted for their political beliefs. Intellectuals were among the first targets in Nazi Germany, seen as threats to Hitler's narratives and his consolidation of power. More recent events in Turkey and Russia show how governments that target dissenters create a climate where citizens are afraid to speak out or pursue truth. An atmosphere of trepidation and uncertainty breaks down society's intellectual foundations, ensuring no one challenges those in power. Importantly, advancement and innovation hinge on our ability to foster a vibrant marketplace of ideas; when diverse ideas are no longer allowed, progress falters.
Whether it's sudden inquisitions, unexplained policy changes, on-again/off-again tariffs or constant threat of job loss, these actions seem designed to foster fear and control. This isn't about efficiency; it's about consolidating power and undermining institutions that hold the government accountable.
If we don't act now, we risk losing the institutions that keep our society open, informed and free. We cannot afford to stay silent while the foundations of our public institutions are eroded. The future of American democracy depends on it.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Business Insider
8 minutes ago
- Business Insider
Trump's former Commerce Secretary, Wilbur Ross, says the US-China deal is still far from comprehensive
President Donald Trump's former Secretary of Commerce doesn't think the trade deal between the US and China is close to being "done." "It looks as though they made a fairly modest deal, mostly focusing on export controls on both the US side and the China side," Wilbur Ross, who was part of the first Trump administration, told Business Insider. "So it's far from a comprehensive deal." On Wednesday morning, Trump said on Truth Social that the deal with China is now "done." "It seems more or less to be reiterating the deal they thought they had set a few weeks ago," Ross said of the deal. China and the US reached a trade framework agreement on Tuesday, after their respective negotiation teams held two-day talks in London. The current Secretary of Commerce, Howard Lutnick, is part of the US trade talk team. "Full magnets, and any necessary rare earths, will be supplied, up front, by China," Trump added in all caps in the post. "Likewise, we will provide to China what was agreed to, including Chinese students using our colleges and universities (which has always been good with me!)." Ross said that the deal has not addressed many important issues, including intellectual property, so it may be too soon to call this a victory. "The Chinese side has been very careful to say it still needs to be approved by President Xi," said Ross. "When we negotiated with the China side last time, it wasn't unusual for the trade negotiators to agree to something, and then they would go back to Xi, and he would not go along with it." This year in duties on imports from China reached up to 245% on some goods. On May 14, many of the tariffs on China were reduced to 30% for 90 days, with a deadline of August 12. A 10% baseline tariff is still in place on the rest of the world, while additional higher tariffs on 75 countries have been paused until July 9. Ross said that it would be important to complete at least a few deals with key trading partners before the tariff pause on 75 countries expires. "I think that will help clear the air for the stock market because it'll start to show a direction and that there is a way to get all these things resolved," he said. "It's very important from a bond market point of view and from an equity market point of view."
Yahoo
10 minutes ago
- Yahoo
Trump Treasury Secretary Suddenly Backtracks on Major Tariff Deadline
Treasury Secretary Scott Bessent indicated that Donald Trump is again intending to move the goalposts for his global tariff policy. The United States is fast approaching the end of the president's 90-day pause on his sweeping global tariffs on July 9, but while testifying before the House Ways and Means Committee on Wednesday, Bessent said that 'Liberation Day' Part 2 may not come to pass so soon. 'I would say, as I have repeatedly said, that there are 18 important trading partners. We are working toward deals on those. And it is highly likely that those countries that are negoti—or trading blocs, in the case of the EU—who are negotiating in good faith, we will roll the date forward to continue good-faith negotiations,' Bessent said. 'If someone is not negotiating, then we will not,' he added. The Trump administration has not even vaguely approached its initial promise to crack 90 deals in 90 days, only announcing two unfinished deals, with the U.K. and China. Crucially, Trump's paltry set of terms with China isn't even a deal. China referred to it as merely a 'framework,' while Commerce Secretary Howard Lutnick said it was a 'handshake for a framework' that both Trump and Chinese President Xi Jinping need to approve. Trump seems intent on running the country's economic policy in 90-day increments, prolonging economic uncertainty that has roiled the markets and sent prices rising. But the president's failure should hardly come as a surprise, as the stated purpose of his tariffs—not to ensure economic prosperity but to bring U.S. trading partners to their knees—defies all logic and reason. With only two half-deals made, and a suddenly unclear horizon, it's not clear how TACO Trump will ever reach the goal of 200 trade deals he'd claimed to have made in April. Especially considering that there aren't even that many countries.


Newsweek
12 minutes ago
- Newsweek
Mushroom Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hofood99 Inc. is recalling packages of their Enoki Mushrooms due to fears the product may be contaminated with listeria. Newsweek reached out to the company via phone for additional comment on Wednesday and left a voicemail. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that Listeria monocytogenes is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. Listeria could also lead to stillbirths or miscarriages in pregnant women, the FDA says. What To Know According to the FDA alert, the mushrooms were distributed nationwide to stores and retailers. The recalled mushrooms are sold in 200-gram green plastic packaging with a with UPC Barcode of 6 976532 310051 seen on the back label. No illnesses or injuries have been reported related to the recalled mushrooms. The mushrooms were distributed by Hofood99 Inc., located at 21903 56th Avenue Oakland Gardens, New York 11364. Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) What People Are Saying The FDA in the alert in part: "The contamination was discovered after samples were collected from a store in Michigan and subsequent analysis by Michigan Department of Agriculture & Rural Development (MDARD) Laboratory Division revealed the presence of Listeria monocytogenes." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued. It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled mushrooms may return the product to the original place of purchase for a full refund or destroy it, the FDA says. People with additional questions may contact the company at (917) 756-9833 weekdays from 9 a.m. to 2 p.m.